KEMPHARM INC (KMPH)
US4884452065 - Common Stock
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -35.23M | -8.55M | -12.76M | -24.52M | -56.47M | |||
| Depreciation Amortization | 708.00K | 257.00K | 270.00K | 300.00K | 320.00K | |||
| Change In Working Capital | -3.79M | -357.00K | 370.00K | -5.12M | -2.29M | |||
| Interest Paid | 170.00K | 218.00K | 80.00K | 5.36M | 5.59M | |||
| Other non cash items | 23.20M | 19.09M | 10.17M | 5.60M | 4.22M | |||
| OPERATING CASH FLOW | -15.10M | 10.44M | -1.94M | -23.74M | -54.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -76.00K | -102.00K | -30.00K | -30.00K | -20.00K | |||
| Other Investing Activity | N/A | -15.42M | N/A | 3.26M | 33.35M | |||
| INVESTING CASH FLOW | -52.09M | -15.52M | -30.00K | 3.23M | 33.33M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 12.77M | -38.10M | 2.86M | 5.24M | -190.00K | |||
| Stock Issued/Repurchased | -7.54M | 77.29M | N/A | 0.00 | 28.40M | |||
| Other Financing Activity | 506.00K | 73.92M | -120.00K | -300.00K | -180.00K | |||
| FINANCING CASH FLOW | 5.74M | 113.11M | 2.74M | 4.94M | 28.02M | |||
| CHANGE IN CASH | -61.44M | 108.02M | 770.00K | -15.57M | 7.15M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -15.10M | 10.44M | -1.94M | -23.74M | -54.20M | |||
| Capital Expenditure | -76.00K | -102.00K | -30.00K | -30.00K | -20.00K | |||
| FREE CASH FLOW | -15.18M | 10.34M | -1.97M | -23.77M | -54.22M | |||
All data in USD